Ifebemtinib tosylate - CAS 2761021-80-9

Ifebemtinib (tosylate) (BI-853520 (tosylate) ; IN-10018 (tosylate) ) is a highly selective PTK2 kinase inhibitor with anti-tumor properties. It inhibits FAK autophosphorylation in prostate cancer cells and suppresses spheroid formation and in situ tumor growth in vivo. Ifebemtinib (tosylate) is applicable in cancer research, including studies on solid tumors, breast cancer, and malignant pleural mesothelioma.

FAK

Cytoskeletal Signaling, Angiogenesis, Tyrosine Kinase/Adaptors

2760932

C35H36F4N6O7S

760.76

O=C(NC1CCN(C)CC1)C=2C=C(OC)C(=CC2F)NC3=NC=C(C(=N3)OC4=CC=CC5=C4C(=O)N(C)C5)C(F)(F)F.O=S(=O)(O)C1=CC=C(C=C1)C

-20°C

Ice Packs

Small Compound